Erxi Wu, assistant professor of pharmaceutical sciences, and his lab published 20 papers on cancer research throughout 2011.
Some of the publications which featured his research include, Journal of Immunology, Journal of Biomedical Informatics, Cancer Letters, PLoS ONE, Journal of Neuro-Oncology, European Journal of Pharmacology and Current Molecular Medicine.
Wu's research areas include tumor therapeutic targets, drug target proteins, biomarkers, drug discovery, natural products, traditional Chinese medicine/complementary and alternative medicine, and pharmacogenomics.
Wu finished his doctorate in biochemistry from Sheffield University Medical School, Sheffield, England, in 1998. He went on to conduct postdoctoral research in cancer biology at the Dana-Farber Cancer Institute at Harvard University. From 2004 to 2008, he led a research group as a faculty member at Children’s Hospital Informatics Program of the Division of Health Sciences and Technology at Harvard-MIT.
He joined NDSU in 2008 as a tenure-track assistant professor in the Department of Pharmaceutical Sciences.